Biotech IPOs surge in H1 of 2026, shattering records and doubling last year’s total
Biotech IPOs surge in H1 of 2026, shattering records and doubling last year’s total
Peptide Libraries for AI Cancer Drug Discovery
Biotech IPOs surge in H1 of 2026, shattering records and doubling last year’s total
Chief Executive Officer
Chief Medical Officer
Chief Scientific Officer